Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) Other Non Operating Income (2020 - 2025)

Definitive Healthcare (DH) has disclosed Other Non Operating Income for 6 consecutive years, with -$7.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 183.06% year-over-year to -$7.4 million, compared with a TTM value of -$1.8 million through Dec 2025, down 121.49%, and an annual FY2025 reading of -$1.8 million, down 102.4% over the prior year.
  • Other Non Operating Income was -$7.4 million for Q4 2025 at Definitive Healthcare, down from $7.1 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $9.0 million in Q4 2024 and bottomed at -$27.1 million in Q4 2021.
  • Average Other Non Operating Income over 5 years is -$1.0 million, with a median of -$93000.0 recorded in 2021.
  • The sharpest move saw Other Non Operating Income skyrocketed 6087.0% in 2022, then plummeted 427.08% in 2025.
  • Year by year, Other Non Operating Income stood at -$27.1 million in 2021, then skyrocketed by 103.18% to $863000.0 in 2022, then soared by 505.33% to $5.2 million in 2023, then soared by 71.34% to $9.0 million in 2024, then plummeted by 183.06% to -$7.4 million in 2025.
  • Business Quant data shows Other Non Operating Income for DH at -$7.4 million in Q4 2025, $7.1 million in Q3 2025, and -$2.0 million in Q2 2025.